Financhill
Back

Hepion Pharmaceuticals Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
23

HEPA
Hepion Pharmaceuticals

Last Price:
0.63
Seasonality Move:
10.8%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Hepion Pharmaceuticals Price Quote

$0.63
-0.01 (-1.56%)
(Updated: November 12, 2024 at 5:55 PM ET)

Hepion Pharmaceuticals Key Stats

Sell
23
Hepion Pharmaceuticals (HEPA) is a Sell

Day range:
$0.62 - $0.65
52-week range:
$0.55 - $4.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.99%

Volume:
18.9K
Avg. volume:
60.5K
1-year change:
-78.88%
Market cap:
$3.7M
Revenue:
$0
EPS:
$-6.4

How Much Does Hepion Pharmaceuticals Make?

Data Unavailable

Is Hepion Pharmaceuticals Growing As A Company?

Data Unavailable

Hepion Pharmaceuticals Stock Price Performance

What Is Hepion Pharmaceuticals 52-Week High & Low?

Hepion Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Hepion Pharmaceuticals?

Is Hepion Pharmaceuticals Cash Flow Positive?

  • What Is HEPA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34.8M
  • What Is Hepion Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $6.3M
  • What Is Hepion Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $2.2K

Hepion Pharmaceuticals Return On Invested Capital

Data Unavailable

Hepion Pharmaceuticals Earnings Date & Stock Price

Hepion Pharmaceuticals Competitors

Hepion Pharmaceuticals Dividend Yield

Hepion Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 38.22%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 4587.5%

Major Shareholders

  • How many HEPA shares are owned by institutional investors?
    984.6K HEPA shares are owned by institutional investors
  • How many HEPA shares are owned by insiders?
    723.5K HEPA shares are owned by insiders